FUM Stock Overview
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Futura Medical plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.36 |
52 Week High | UK£0.53 |
52 Week Low | UK£0.23 |
Beta | 1.25 |
11 Month Change | 6.34% |
3 Month Change | 4.73% |
1 Year Change | -29.81% |
33 Year Change | -14.12% |
5 Year Change | 14.06% |
Change since IPO | -48.95% |
Recent News & Updates
Recent updates
Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)
Sep 13We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth
Apr 17Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation
Jan 05Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?
Jul 28We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully
Mar 18We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate
Sep 25Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation
May 10We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow
Jan 10What We Learned About Futura Medical's (LON:FUM) CEO Compensation
Dec 21Shareholder Returns
FUM | GB Pharmaceuticals | GB Market | |
---|---|---|---|
7D | -2.7% | -2.9% | -0.1% |
1Y | -29.8% | 10.6% | 5.7% |
Return vs Industry: FUM underperformed the UK Pharmaceuticals industry which returned 14.8% over the past year.
Return vs Market: FUM underperformed the UK Market which returned 7.1% over the past year.
Price Volatility
FUM volatility | |
---|---|
FUM Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 4.6% |
10% most volatile stocks in GB Market | 9.2% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: FUM has not had significant price volatility in the past 3 months.
Volatility Over Time: FUM's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 12 | James Barder | www.futuramedical.com |
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc Fundamentals Summary
FUM fundamental statistics | |
---|---|
Market cap | UK£110.18m |
Earnings (TTM) | -UK£3.75m |
Revenue (TTM) | UK£8.40m |
13.1x
P/S Ratio-29.4x
P/E RatioIs FUM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FUM income statement (TTM) | |
---|---|
Revenue | UK£8.40m |
Cost of Revenue | UK£2.71m |
Gross Profit | UK£5.69m |
Other Expenses | UK£9.44m |
Earnings | -UK£3.75m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 67.70% |
Net Profit Margin | -44.68% |
Debt/Equity Ratio | 0% |
How did FUM perform over the long term?
See historical performance and comparison